Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation
Despite strict pre- and post-transplantation screening, the incidence of new-onset diabetes after transplantation (NODAT) remains as high as 60%. This complication affects the risk of cardiovascular events and patient and graft survival rates. Thus, reducing the impact of NODAT could improve overall...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Association of Internal Medicine
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642005/ |